Coulter Pharmaceutical Report issue

Contributed to NME For profit Phase 3
Founded: South San Francisco CA United States (1995)
Status: Acquired by Corixa (2000) → now GlaxoSmithKline (2005)

Organization Overview

First Clinical Trial
1998
NCT00004874
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Coulter Pharmaceutical, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

tositumomab (Bexxar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1